Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Outstanding Shares...See also Convertible Debentures

Oct 13, 2006 03:39PM
Sec. 8 starting on page F-17. Ease: I believe the 316,100,499 and 412,963,173 are correct for a given period. However, it looks like they retired some of the warrants, which some here felt needed to be done before we started any share buy back. In retiring the warrants and debentures (which weren't completely gone due to the restatement requirements) The company had to issue someone "more shares" to satisfy the warrant/debenture retirement. LOL. Just try telling all that to someone... I may be all wrong and am certainly not qualified to comfirm this is what happened. Anyone else care to look over that section? My apologies if this is way off base.
Share
New Message
Please login to post a reply